Search - tctmd.com

Displaying 41 - 60 of 94

Sort: Relevancy | Date

Presentation TVT 2021

How ACURATE neo2 Improves Outcomes

Presenter: Won-Keun Kim

July 20, 2021

Presentation TVT 2021

Early neo2 Registry. Full Core-lab Results of TAVI With the New Acurate neo2 Valve

Presenter: Andreas Ruck

July 20, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2020

Shelley Wood

November 30, 2020

News Daily News

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

Michael O'Riordan

November 18, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

Podcast TCTMD Talking Points

SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic Stenosis

January 22, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

Presenter: Ariana Gonzálvez-García

September 29, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Presenter: Kendra Grubb

September 27, 2019

Presentation TCT 2019

Real-World Experience of the LOTUS Edge Valve

Presenter: Hemal Gada

September 27, 2019

Presentation TCT 2019

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

Presenter: Thomas Pilgrim

September 27, 2019

Presentation TCT 2019

ACURATE neo: Features and Benefits for Optimized TAVR

Presenter: Helge Möllmann

September 27, 2019

Presentation TCT 2019

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Presenter: Jonas Lanz

September 27, 2019

Advertisement

How ACURATE neo2 Improves Outcomes

Early neo2 Registry. Full Core-lab Results of TAVI With the New Acurate neo2 Valve

TCTMD’s Top 10 Most Popular Stories for November 2020

Lotus Edge TAVR Device Recalled and Discontinued Worldwide

TCTMD’s Top 10 Most Popular Stories for October 2020

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Which TAVR Device Is Best? Review Tackles Optimal Selection

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic Stenosis

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Comparison of Clinical Events of Two New-Generation Supra-annular Self-expanding Transcatheter Aortic Valves (Allegra versus ACURATE neo).

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Mitigating a Devastating Outcome: SENTINEL CPS in TAVR

Real-World Experience of the LOTUS Edge Valve

Lessons From the SCOPE I Study and the ACURATE neo Body of Evidence

ACURATE neo: Features and Benefits for Optimized TAVR

SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content